GYRE

GYRE Operating Expenses

$129.25MTTM · USD

Period ending:

GYRE FY Operating ExpensesUSD
GYRE FY Operating Expenses2001-12-31: $10.45M2002-12-31: $23.05M2003-12-31: $21.78M2004-12-31: $27.93M2005-12-31: $30.64M2006-12-31: $27.48M2007-12-31: $42.63M2008-12-31: $47.48M2009-12-31: $64.70M2010-12-31: $70.60M2011-12-31: $104.90M2012-12-31: $62.28M2013-12-31: $50.85M2014-12-31: $8.64M2015-12-31: $15.55M2016-12-31: $20.82M2017-12-31: $22.67M2018-12-31: $33.83M2019-12-31: $57.13M2020-12-31: $69.16M2021-12-31: $83.39M2022-12-31: $88.29M2023-12-31: $176.04M2024-12-31: $85.71M2025-12-31: $99.68M$176.04M$0.00
2001-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

GYRE operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 25 observations from Dec 31, 2001 to Dec 31, 2025.

Gyre Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
99,681,000
85,710,000
176,044,000
88,294,000
83,394,000
69,155,000
57,131,000
33,828,000
22,667,000
20,817,000
15,552,000
8,642,000
50,845,000
62,280,000
104,902,000
70,601,000
64,696,000
47,480,000
42,632,088
27,484,000
30,639,900
27,933,355
21,779,000
23,045,000
10,454,000

Compare operating expenses

All GYRE financial metrics · GYRE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.